The original mdr 1217157-2014-00035 was filed with fda on march 09, 2014.Additional information & corrections: this data was reviewed with siemens medical affairs with following conclusion: the maximal 1.5 g/dl difference in the patient total hemoglobin(thb) values are an estimate of potential blood loss but not an absolute.In the cases of volumic loss, a number of parameters are assessed to determine the need for red cell replacement over fluids and osmotic support.Because this additional information was not available for the initial filed mdr, the mdr was filed.Had this additional information been available, this event would have been assessed as not require filing mdr as per 21 cfr 803.
|